IUS Publications
Found 28 results
Filters: Author is Sabina Semiz [Clear All Filters]
“Genetic Counseling and Preventive Medicine in Bosnia and Herzegovina”, in Center for Human Rights and Transitional Justice, Faculty of Law, IUS, 2019.
, “Precision Medicine in the Era of CRISPR-Cas9: Evidence from Bosnia and Herzegovina”, Palgrave Communications, 2019.
, “BH education without borders: "Knowledge is donorable and sharable",”, Days of the Bosnian-Herzegovinian American Academy of Arts and Sciences (BHAAAS) in B&H, Neum, BH, . 2016.
, “The Bosnia and Herzegovina Unit of the UNESCO Chair in Bioethics”, Bioethical Voices, vol. 2 (5), 2016.
, “Metabolomics Prediction of Future Type 2 Diabetes, ”, 40th Anniversary of the Dutch Epidemiology Conference, Wageningen, Netherland. 2016.
, “Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes.”, Diabet Med, vol. 33, no. 4, pp. 511-4, 2016.
, Personalized Therapy of Type 2 Diabetes. Sarajevo: International University of Sarajevo, 2016.
, “Pharmacogenomics of membrane transporters and metformin response in Type 2 diabetic patients”, European Journal of Human Genetics. 2016.
, Type 2 Diabetes: From Genes to Prognosis and Therapy. Sarajevo: International University of Sarajevo, 2016.
, “Use of Databases for Early Recognition of Risk of Diabetic Complication by Analysis of Liver Enzymes in Type 2 Diabetes Mellitus.”, Acta Inform Med, vol. 24, no. 2, pp. 90-3, 2016.
, “Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin.”, Nat Genet, vol. 48, no. 9, pp. 1055-9, 2016.
, “THE ASSOCIATION BETWEEN COMMONLY USED INFLAMMATORY MARKERS AND URIC ACID IN PREDIABETES”, IFCC-EFLM EuroMedLab Paris 2015 Congress, Paris, France. 2015.
, “THE ASSOCIATION BETWEEN COMMONLY USED INFLAMMATORY MARKERS AND URIC ACID IN PREDIABETES”, in Clinical Chemistry and Laboratory Medicine, 53, S1, S605, 2015.
, “Association of LPIN1 gene variations with markers of metabolic syndrome in population from Bosnia and Herzegovina.”, Med Glas (Zenica), vol. 12, no. 2, pp. 113-21, 2015.
, “ASSOCIATIONS OF SOLUTE CARRIER TRANSPORTERS GENE VARIATIONS WITH MARKERS OF TYPE 2 DIABETES AND ITS COMPLICATIONS – GENDER SPECIFIC?”, in Clinical Chemistry and Laboratory Medicine, 53, S1, S650, 2015.
, “ASSOCIATIONS OF SOLUTE CARRIER TRANSPORTERS GENE VARIATIONS WITH MARKERS OF TYPE 2 DIABETES AND ITS COMPLICATIONS – GENDER SPECIFIC?”, IFCC-EFLM EuroMedLab Paris 2015 Congress, Paris, France. 2015.
, “Cardiovascular Pharmacogenomics”, “Pharmacogenomics – From Research to Clinic” Workshop for university lecturers, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. 2015.
, “DIAGNOSTIC RELEVANCE OF INFLAMMATORY MARKERS IN PREDIABETIC PATIENTS”, IFCC-EFLM EuroMedLab Paris 2015 Congress, Paris, France. 2015.
, “DIAGNOSTIC RELEVANCE OF INFLAMMATORY MARKERS IN PREDIABETIC PATIENTS”, in Clinical Chemistry and Laboratory Medicine, 53, S1, S646, 2015.
, “Education in Bioethics”, 2nd International Conference on Education, Culture and Identity (ICECI), International University of Sarajevo. 2015.
, “Education in Bioethics, 2nd International Conference on Education”, Culture and Identity (ICECI), International University of Sarajevo, Sarajevo, Bosnia and Herzegovina. 2015.
, “Ethical issues in pharmacogenomics and personalized medicine”, UNESCO Conference “BIOETHICS, MEDICAL ETHICS & HEALTH LAW”, Naples, Italy. 2015.
, “FREE FATTY ACIDS AND LIVER INFLAMMATION IN TYPE 2 DIABETIC WOMEN”, in Clinical Chemistry and Laboratory Medicine, 53, S1, S647, 2015.
, “FREE FATTY ACIDS AND LIVER INFLAMMATION IN TYPE 2 DIABETIC WOMEN”, IFCC-EFLM EuroMedLab Paris 2015 Congress, Paris, France. 2015.
, “The OCT1 reduced-function polymorphisms are associated with metformin-induced gastrointestinal side-effects,”, in Diabetologia 58 (Suppl. 1.), s110, 2015; Presented at European Association for the Study of Diabetes- 51 EASD Annual Meeting, 2015.
, “Pharmacogenomic Variations and Metformin Response”, 3rd ESPT Conference “Integration of Pharmacogenomics in clinical decision support”, Budapest, Hungary. 2015.
, “Pharmacogenomics and Personalized Treatment of Type 2 Diabetes”, “Pharmacogenomics – From Research to Clinic” Workshop for university lecturers, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. 2015.
, “Prediabetes incidence and risk of developing cardiovascular disease in women with polycystic ovary syndrome”, Endocrine Abstracts, 38, P268. 2015.
,